H

E

HOLLER , Ernst

Last name: HOLLER

First name: Ernst

2021 (v1)

Publication

Metadata-only

Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study

Styczyński, Jan Tridello, Gloria Xhaard, Alienor

Letermovir (LMV) is licensed for prophylaxis of CMV infection in allogeneic hematopoietic cell transplant adult CMV-seropositive patients. Due to its favorable safety profile, LMV brings potential for use in other clinical situations, outside the approved indication. The objective of the study was to analyze the efficacy and safety of the use...

Uploaded on: February 14, 2024